Thomas J. Kipps
Thomas J. Kipps
Professor of Medicine, UC San Diego
Verified email at ucsd.edu
Title
Cited by
Cited by
Year
Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia
GA Calin, CD Dumitru, M Shimizu, R Bichi, S Zupo, E Noch, H Aldler, ...
Proceedings of the national academy of sciences 99 (24), 15524-15529, 2002
56692002
miR-15 and miR-16 induce apoptosis by targeting BCL2
A Cimmino, GA Calin, M Fabbri, MV Iorio, M Ferracin, M Shimizu, ...
Proceedings of the National Academy of Sciences 102 (39), 13944-13949, 2005
39792005
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National …
M Hallek, BD Cheson, D Catovsky, F Caligaris-Cappio, G Dighiero, ...
Blood, The Journal of the American Society of Hematology 111 (12), 5446-5456, 2008
31152008
A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia
GA Calin, M Ferracin, A Cimmino, G Di Leva, M Shimizu, SE Wojcik, ...
New England Journal of Medicine 353 (17), 1793-1801, 2005
27322005
MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias
GA Calin, CG Liu, C Sevignani, M Ferracin, N Felli, CD Dumitru, ...
Proceedings of the National Academy of Sciences 101 (32), 11755-11760, 2004
16132004
Idelalisib and rituximab in relapsed chronic lymphocytic leukemia
RR Furman, JP Sharman, SE Coutre, BD Cheson, JM Pagel, P Hillmen, ...
New England Journal of Medicine 370 (11), 997-1007, 2014
14592014
Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia
A Rosenwald, AA Alizadeh, G Widhopf, R Simon, RE Davis, X Yu, L Yang, ...
The Journal of experimental medicine 194 (11), 1639-1648, 2001
12652001
CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment
JA Burger, TJ Kipps
Blood 107 (5), 1761-1767, 2006
12292006
Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia
JC Byrd, JR Brown, S O'Brien, JC Barrientos, NE Kay, NM Reddy, ...
New England Journal of Medicine 371 (3), 213-223, 2014
12232014
ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia
LZ Rassenti, L Huynh, TL Toy, L Chen, MJ Keating, JG Gribben, ...
New England Journal of Medicine 351 (9), 893-901, 2004
10682004
Targeting BCL2 with venetoclax in relapsed chronic lymphocytic leukemia
AW Roberts, MS Davids, JM Pagel, BS Kahl, SD Puvvada, JF Gerecitano, ...
New England Journal of Medicine 374 (4), 311-322, 2016
10322016
Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors.
F Fais, F Ghiotto, S Hashimoto, B Sellars, A Valetto, SL Allen, P Schulman, ...
The Journal of clinical investigation 102 (8), 1515-1525, 1998
9511998
Ibrutinib as initial therapy for patients with chronic lymphocytic leukemia
JA Burger, A Tedeschi, PM Barr, T Robak, C Owen, P Ghia, O Bairey, ...
New England Journal of Medicine 373 (25), 2425-2437, 2015
8472015
MiR-15a and miR-16-1 cluster functions in human leukemia
GA Calin, A Cimmino, M Fabbri, M Ferracin, SE Wojcik, M Shimizu, ...
Proceedings of the National Academy of Sciences 105 (13), 5166-5171, 2008
8002008
Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell–derived factor-1
JA Burger, N Tsukada, M Burger, NJ Zvaifler, M Dell'Aquila, TJ Kipps
Blood, The Journal of the American Society of Hematology 96 (8), 2655-2663, 2000
7742000
Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181
Y Pekarsky, U Santanam, A Cimmino, A Palamarchuk, A Efanov, ...
Cancer research 66 (24), 11590-11593, 2006
7472006
Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas
GA Calin, C Liu, M Ferracin, T Hyslop, R Spizzo, C Sevignani, M Fabbri, ...
Cancer cell 12 (3), 215-229, 2007
7422007
Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal.
EA Ranheim, TJ Kipps
The Journal of experimental medicine 177 (4), 925-935, 1993
6741993
Substantial susceptibility of chronic lymphocytic leukemia to BCL2 inhibition: results of a phase I study of navitoclax in patients with relapsed or refractory disease
AW Roberts, JF Seymour, JR Brown, WG Wierda, TJ Kipps, SL Khaw, ...
Journal of Clinical Oncology 30 (5), 488, 2012
6682012
Ofatumumab as single-agent CD20 immunotherapy in fludarabine-refractory chronic lymphocytic leukemia
WG Wierda, TJ Kipps, J Mayer, S Stilgenbauer, CD Williams, A Hellmann, ...
Journal of Clinical Oncology 28 (10), 1749, 2010
6632010
The system can't perform the operation now. Try again later.
Articles 1–20